The Food and Drug Administration has awarded Booz Allen Hamilton (NYSE: BAH) and Octo Consulting Group spots on a potential seven-year, $300 million blanket purchase agreement to update data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback